Up-regulation of MiR-452 inhibits metastasis of non-small cell lung cancer by regulating BMI1

Cellular Physiology and Biochemistry

Volumn 37, Issue 1, 2015, Pages 387-398

  He, Zhicheng ^a   Xia, Yang ^a   Pan, Chunfeng ^a   Ma, Teng ^a   Liu, Bin ^a   Wang, Juejin ^b   Chen, Liang ^a   Chen, Yijiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

BMI1; Invasion; MiR 452; Non small cell lung cancer

Indexed keywords

BMI1 PROTEIN; MICRORNA; MICRORNA 452; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; BMI1 PROTEIN, HUMAN; MIRN452 MICRORNA, HUMAN;

ADULT; ARTICLE; ASSAY; CANCER STAGING; CELL INVASION; DOWN REGULATION; FEMALE; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUCIFERASE ASSAY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSWELL ASSAY; UPREGULATION; WESTERN BLOTTING; 3' UNTRANSLATED REGION; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

3' UNTRANSLATED REGIONS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MICRORNAS; NEOPLASM INVASIVENESS; POLYCOMB REPRESSIVE COMPLEX 1; UP-REGULATION;

EID: 84941030696     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430362     Document Type: Article

References (26)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A: Global cancer statistics, 2012. CA Cancer ] Clin 2015;65:87-108
2. Chen W, Zheng R, Zhang S, Zhao P, Zeng H, Zou X: Report of cancer incidence and mortality in china, 2010. Ann Transl Med 2014;2:61
3. Siegel R, Ma J, Zou Z, Jemal A: Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29
4. Furak J, Trojan I, Szoke T, Agocs L, Csekeo A, Kas J, Svastics E, Eller J, Tiszlavicz L: Lung cancer and its operable brain metastasis: Survival rate and staging problems. Ann Thorac Surg. 2005;79:241-247; discussion 241-247
5. Yang WB, Chen PH, Hsu Ts, Fu TF, Su WC, Liaw H, Chang WC, Hung JJ: Spl-mediated microrna-182 expression regulates lung cancer progression. Oncotarget 2014;5:740-753
6. Liu SG, Qin XG, Zhao BS, Qi B, Yao WJ, Wang TY, Li HC, Wu XN: Differential expression of mirnas in esophageal cancertissue. Oncol Lett 2013;5:1639-1642
7. Liu L, Chen K, Wu J, Shi L, Hu B, Cheng S, Li M, Song L: Downregulation of mir-452 promotes stem-like traits and tumorigenicity of gliomas. Clin Cancer Res 2013;19:3429-3438
8. van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dan PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ: Expression profiling of cancerous and normal breast tissues identifies micrornas that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers. Breast Cancer Res 2012;14:R34
9. Liu C, Kelnar K, Vlassov AV, Brown D, Wang J, Tang DG: Distinct microrna expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7. Cancer Res 2012;72:3393-3404
10. Zhang X, Yang X, Zhang Y, Liu X, Zheng G, Yang Y, Wang L, Du L, Wang C: Direct serum assay for cell-free bmi-1 mrna and its potential diagnostic and prognostic value for colorectal cancer. Clin Cancer Res 2015;21:1225-1233
11. Jin M, Zhang T, Liu C, Badeaux MA, Liu B, Liu R, Jeter C, Chen X, Vlassov AV, Tang DG: Mirna-128 suppresses prostate cancer by inhibiting bmi-1 to inhibit tumor-initiating cells. Cancer Res 2014;74:4183-4195
12. Becker M, Korn C, Sienerth AR, Voswinckel R, Luetkenhaus K, Ceteci F, Rapp UR: Polycomb group protein bmil is required for growth of raf driven non-small-cell lung cancer. PLoS One 2009;4:e4230
13. Jiang L, Li J, Song L: Bmi-1, stem cells and cancer. Acta Biochim Biophys Sin (Shanghai) 2009;41:527-534
14. Detterbeck FC, Boffa DJ, Tanoue LT: The new lung cancer staging system. Chest 2009;136:260-271
15. Xia Y, Chen Q, Zhong Z, Xu C, Wu C, Liu B, Chen Y: Down-regulation of mir-30c promotes the invasion of non-small cell lung cancer by targeting mtal. Cell Physiol Biochem 2013;32:476-485
16. Xia Y, Zhu Y, Ma T, Pan C, Wang J, He Z, Li Z, Qi X, Chen Y: Mir-204 functions as a tumor suppressor by regulating sixl in nsclc. FEBS Lett 2014;588:3703-3712
17. Yan GJ, Yu F, Wang B, Zhou HJ, Ge QY, Su J, Hu YL, Sun HX, Ding LJ: Microrna mir-302 inhibits the tumorigenicity of endometrial cancer cells by suppression of cyclin dl and cdkl. Cancer Lett 2014;345:39-47
18. Yongchun Z, Linwei T, Xicai W Lianhua Y, Guangqiang Z, Ming Y, Guanjian L, Yujie L, Yunchao H: Microrna-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting myb. Cancer Lett 2014;347:65-74
19. Gu XY, Wang J, Luo YZ, Du Q, Li RR, Shi H, Yu TP: Down-regulation of mir-150 induces cell proliferation inhibition and apoptosis in non-small-cell lung cancer by targeting bakl in vitro. Tumour Biol 2014;35:5287-5293
20. Kristensen H, Haldrup C, Strand S, Mundbjerg K, Mortensen MM, Thorsen K, Ostenfeld MS, Wild PJ, Arsov C, Goering W, Visakorpi T, Egevad L, Lindberg J, Gronberg H, Hoyer S, Borre M, Orntoft TF, Sorensen KD: Hypermethylation of the gabre~mir-452~mir-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy. Clin Cancer Res 2014;20:2169-2181
21. Veerla S, Lindgren D, Kvist A, Frigyesi A, Staaf J, Persson H, Liedberg F, Chebil G, Gudjonsson S, Borg A, Mansson W, Rovira C, Hoglund M: Mirna expression in urothelial carcinomas: Important roles of mir-10a, mir-222, mir-125b, mir-7 and mir-452 for tumor stage and metastasis, and frequent homozygous losses of mir-31. Int J Cancer 2009;124:2236-2242
22. Zheng Q, Sheng Q, Jiang C, Shu J, Chen J, Nie Z, Lv Z, Zhang Y: Microrna-452 promotes tumorigenesis in hepatocellular carcinoma by targeting cyclin-dependent kinase inhibitor lb. Mol Cell Biochem 2014;389:187-195
23. van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, Berns A: Identification of cooperating oncogenes in e mu-myc transgenic mice by provirus tagging. Cell 1991;65:737-752
24. Kim JH, Yoon SY, Jeong SH, Kim SY, Moon SK, Joo JH, Lee Y, Choe IS, Kim JW: Overexpression of bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast (Edinburgh, Scotland) 2004;13:383-388
25. Li DW, Tang HM, Fan JW, Yan DW, Zhou CZ, Li SX, Wang XL, Peng ZH: Expression level of bmi-1 oncoprotein is associated with progression and prognosis in colon cancer. J Cancer Res Clin Oncol 2010;136:997-1006
26. MengX, Wang Y, Zheng X, Liu C, Su B, Nie H, Zhao B, Zhao X, Yang H: Shrna-mediated knockdown of bmi-1 inhibit lung adenocarcinoma cell migration and metastasis. Lung Cancer 2012;77:24-30